EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative genomic and clinical analysis of carbapenem-resistant and susceptible Klebsiella pneumoniae isolates from a tertiary hospital in Wuhan

Mengling Liu, Zhiyong Wu, Jieyu Mao, Shuo Zhang, Sheng Xu, Jinwen Min, Wenjing Yu, Haizhou Liu, Yangbo Hu, Xiaojun Wu

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1881548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Mengling Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Carbapenems, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major global health threat due to its resistance to carbapenems. As the mechanisms underlying carbapenem resistance in CRKP remain incompletely understood, we seek to provide important insights into the clinical and genomic characteristics of CRKP.

Methods

A total of 40 CRKP and 42 carbapenem-susceptible Klebsiella pneumoniae (CSKP) isolates were collected from a tertiary hospital in Wuhan, China. Integrating 2,460 publicly available Klebsiella pneumoniae genomes, we conducted a comprehensive analysis of clinical risk factors, resistance and virulence gene profiles, plasmid replicon composition, core genome SNP-based phylogeny, pan-genome structure, and genome-wide single-nucleotide variants and insertions/deletions (SNVs/InDels) variation.

Results

Clinical analysis identified a Charlson comorbidity index > 3 and respiratory tract infections as independent risk factors for CRKP infection. Genomic comparisons revealed that CRKP strains harbored more resistance and virulence genes than CSKP strains, with ST11 being the dominant CRKP clone that frequently carried the blaKPC-2 gene. Phylogenetic analysis incorporating public genomes revealed regional differences in sequence type and carbapenemase genotype distributions. Pan-genome analysis demonstrated open pan-genome characteristics in both groups, with cloud genes representing the largest gene category. Comparative genomic analyses revealed distinct SNV and InDel distribution patterns between CRKP and CSKP isolates, while GO annotation of the prioritized variant-associated genes showed broad functional representation across cellular and metabolic processes, transport and responses to stimuli, membrane-associated components, and binding and catalytic functions.

Conclusions

CCI >3 and respiratory tract infection were independently associated with CRKP infection. ST11- blaKPC-2 was the predominant epidemic lineage and CRKP isolates carried a greater burden of resistance and virulence determinants than CSKP isolates. Phylogenetic, pan-genomic, and comparative genomic analyses revealed substantial genomic diversity and distinct genomic variation patterns between CRKP and CSKP. These findings provide insights into the clinical risk profile, clonal dynamics, and genomic evolution of CRKP, informing future surveillance and infection control strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsCarbapenemsCarbapenem-Resistant EnterobacteriaceaeTertiary Care CentersHumansChinaPhylogenyGenome, BacterialAnti-Bacterial AgentsVirulence FactorsGenomicsPolymorphism, Single Nucleotidebeta-LactamasesMicrobial Sensitivity TestsPlasmidsRisk FactorsVirulence

Stichwörter der Autor:innen

carbapenem-resistant Klebsiella pneumoniaecarbapenem-susceptible Klebsiella pneumoniaeclinical risk factorscomparative genomicspan-genome

Substanzen

CarbapenemsAnti-Bacterial AgentsVirulence Factorsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • University of Chinese Academy of Sciences, Beijing, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, M., Wu, Z., Mao, J., Zhang, S., Xu, S., Min, J., Yu, W., Liu, H., Hu, Y., & Wu, X. (2026). Integrative genomic and clinical analysis of carbapenem-resistant and susceptible Klebsiella pneumoniae isolates from a tertiary hospital in Wuhan. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1881548

Vancouver

Liu M, Wu Z, Mao J, Zhang S, Xu S, Min J, et al. Integrative genomic and clinical analysis of carbapenem-resistant and susceptible Klebsiella pneumoniae isolates from a tertiary hospital in Wuhan. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1881548

BibTeX
@article{Liu2026,
  author = {Liu, Mengling and Wu, Zhiyong and Mao, Jieyu and Zhang, Shuo and Xu, Sheng and Min, Jinwen and Yu, Wenjing and Liu, Haizhou and Hu, Yangbo and Wu, Xiaojun},
  title = {Integrative genomic and clinical analysis of carbapenem-resistant and susceptible Klebsiella pneumoniae isolates from a tertiary hospital in Wuhan},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1881548}
}
Kostenlos starten →